Myaza Injection

उत्पाद अवलोकन

About Myaza Injection

Myaza Injection is a medication containing the active ingredient azacitidine, classified as Nucleoside Metabolic Inhibitor. Azacitidine, sold under the brand name Vidaza among others, is a medication used for the treatment of myelodysplastic syndrome, myeloid leukemia, and juvenile myelomonocytic leukemia. It is a chemical analog of cytidine, a nucleoside in DNA and RNA.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Azacitidine for injection is a nucleoside metabolic inhibitor indicated for the treatment of: Adult patients with the.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

azacitidine, the active ingredient in Myaza Injection, belongs to the Nucleoside Metabolic Inhibitor class. 1 INDICATIONS AND USAGE Azacitidine for injection is a nucleoside metabolic inhibitor indicated for the treatment of: Adult patients with the following FAB myelodysplastic syndrome (MDS) subtypes: Refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Myaza Injection. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Myaza Injection for extended periods without medical advice.